Results 71 to 80 of about 8,720 (195)

Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers

The Journal of Headache and Pain, 2018
Background Previous studies indicate that sumatriptan is not effective when second messenger levels are high as after cilostazol provocation. Therefore, we have conducted the present study, where sumatriptan is administrated as pretreatment before cAMP ...
Katrine Falkenberg, Jes Olesen
doaj   +1 more source

Dual Antiplatelet Therapy in Acute Branch Atheromatous Disease (BAD)‐Related Stroke: A Multicenter Propensity‐Matched Cohort Analysis

CNS Neuroscience &Therapeutics, Volume 32, Issue 7, July 2026.
The study aimed to compare the clinical outcomes of dual antiplatelet therapy (DAPT) vs. single antiplatelet therapy (SAPT) in branch atheromatous disease (BAD)‐related stroke. DAPT was safe but not statistically superior to SAPT for excellent functional outcome; however, its numerical trend toward benefit warrants further investigation.
Haizhou Hu, Shengde Li, Yu Zhang, Yuhui Sha, Yaping Zhou, Feng Feng, Yicheng Zhu, Lixin Zhou, Bin Peng, Jun Ni, on behalf of BAD‐study investigators   +10 more
wiley   +1 more source

Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytes

Toxicology Reports
Background: Nedaplatin has demonstrated remarkable efficacy in combating various malignancies. However, the administration of nedaplatin has been associated with the induction of DNA damage within normal cells.
Karem H. Alzoubi, Abeer M. Rababa’h, Omar F. Khabour, Fian Nuseir   +3 more
doaj   +1 more source

Transcriptomic analysis reveals Cilostazol's role in ameliorating cardiovascular disease: Inhibition of monocyte-to-macrophage differentiation and reduction of endothelial cell reactive oxygen species production

Heliyon
Background: Cardiovascular diseases (CVDs) are the leading global cause of death, with atherosclerosis as the primary cause. Chronic inflammation, endothelial dysfunction, and the role of molecules like nitric oxide and reactive oxygen species are ...
Chia-Ning Fan, Tsung-Neng Tsai, Xin-Jie Lu, Hsing-Fan Lai, Chun-Hua Wang, Yi-Lin Chiu   +5 more
doaj   +1 more source

Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: Evaluation using black blood magnetic resonance imaging

Neurobiology of Disease, 2008
The purpose of this study was to use black blood magnetic resonance imaging (BB-MRI) to assess delayed cerebral vasospasm (DCV) after subarachnoid hemorrhage (SAH) in rats, and evaluate whether delayed treatment with the anti-platelet agent cilostazol ...
Hideki Ito, Mari Fukunaga, Hidenori Suzuki, Goro Miyakoda, Makoto Ishikawa, Youichi Yabuuchi, Waro Taki   +6 more
doaj   +1 more source

Impact of Cilostazol Administration on Femoropopliteal In-Stent Restenosis

, 2017
Purpose: To investigate whether administering cilostazol after treatment for femoropopliteal in-stent restenosis (ISR) can have a positive impact on recurrent ISR (Re-ISR).
Osamu Iida, Yoshimitsu Soga, Yusuke Tomoi, Kenji Ando, Masahiko Fujihara   +4 more
core   +1 more source

Cilostazol protects against degenerative cervical myelopathy injury and cell pyroptosis via TXNIP-NLRP3 pathway

Cell Division
Degenerative cervical myelopathy (DCM) is one of the most common and serious neurological diseases. Cilostazol has protective effects of anterior horn motor neurons and prevented the cell apoptosis. However, there was no literatures of Cilostazol on DCM.
Fei Xu, Zhuo Tian, Zhengguang Wang
doaj   +1 more source

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention

, 2015
Mei Wang, Guoru Zhang, Yaling Wang, Kun Zhou, Tao Liu, Yang Zhang, Anjun Guo, Yu An, Xiaodan Zhang, Yongjun Li Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China Objective: To
Wang M, Wang YL, Guo AJ, Zhang XD, Zhang Y, An Y, Zhang GR, Li YJ, Liu T, Zhou K   +9 more
core  

Safety and efficacy of cilostazol in the management of intermittent claudication

, 2008
Yung-Wei Chi, Carl J Lavie, Richard V Milani, Christopher J WhiteDepartment of Cardiology, Ochsner Clinic Foundation, New Orleans, LA, USAAbstract: Peripheral arterial disease (PAD) is a major health problem affecting millions of patients worldwide. Many
Yung-Wei Chi, Richard V Milani, Christopher J White, Carl J Lavie   +3 more
core  

Cilostazol: A Drug Particularly Effective for Asians?

, 2011
Cilostazol is an antiplatelet drug often used in Asia; however, it is rarely used in the western hemisphere, particularly for stroke patients. Further studies of cilostazol in other ethnicities are required to prove or disprove whether this drug is also
Jong S. Kim, Yukito Shinohara
core   +1 more source